William Hornung
Diffusion Pharmaceuticals Inc. in Charlottesville has promoted William Hornung to chief financial officer.
Diffusion is a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it’s needed most.
Hornung previously was chief business officer at the company. During his time in that role, Diffusion raised $12 million in an underwritten public offering, began enrolling patients for a phase three study for glioblastoma brain cancer and the FDA approval to enroll patients in an ambulance-based Phase 2 clinical trial testing of its lead drug for the treatment of acute stroke.
